Nearly 2.1 million new cases of breast cancer are diagnosed worldwide each year, and more than 620,000 people will die from the disease.1 About 15 to 20 percent of women diagnosed with breast cancer are HER2 positive.2 VENTANA HER2 Dual ISH DNA Probe Cocktail assay3 aids in identifying HER2-positive breast cancer patients eligible for the... Read more
From the journal: Tetrahedron Abstract During our continuous investigation on a Thai traditional medicinal plant, Stephania venosa Spreng, an alkaloid that seemed to be O-methyldehydrobulbocapnine (MDB) or dehydrocrebanine (DC), had been isolated. However, none of the previously reported 1H- and 13C-NMR data for MDB and DC matched our charts. Thus, we herein report the unambiguous determination of the... Read more
COVACTA trial did not meet its primary endpoint of improved clinical status in patients with COVID-19 associated pneumonia, or the key secondary endpoint of reduced patient mortality The study is the first global, randomised, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting Roche remains committed to continuing the Actemra/RoActemra clinical trial programme in... Read more
CALIFORNIA LABORATORIES CAN NOW INSTANTLY TRANSMIT COVID-19 DATA TO THE CALREDIE SYSTEM IRVINE, Calif., (July 28, 2020) — Zymo Research recently has released a free open-source software program that allows California laboratories to rapidly report COVID-19 test data to the California Reportable Disease Information Exchange (CalREDIE). According to the California Department of Public Health (CDPH) website,... Read more
Revenue of $811.7 million; 12% reported growth; 13% organic growth GAAP EPS from continuing operations of $1.23; Adjusted EPS of $1.57 WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 28, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the second quarter ended July 5, 2020. The Company reported... Read more
Chemical Analyzer Now Enhances Identification of Low Dose Concentration of Illegal Substances Thermo Scientific Gemini Analyzer with LowDoseID for narcotics analysis eliminates concentration limitations from testing process TEWKSBURY, Mass., July 28, 2020 /PRNewswire/ — New trends in the manufacture and distribution of illicit narcotics to include low, distributed concentrations to offset high chemical potency has created... Read more
‘The End of Football’ is Manchester City and Xylem’s latest effort to educate one billion people globally about urgent water challenges RYE BROOK, N.Y. –(BUSINESS WIRE)–Jul. 28, 2020– Manchester City stars Sergio Agüero, Phil Foden and Raheem Sterling all feature in an emotive new short film Read more
Thermo Fisher Scientific and Lyell Immunopharma Form Cell Therapy Manufacturing Partnership Collaboration will include development of Thermo Fisher products and strategic manufacturing support WALTHAM, Mass., July 28, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, and biotechnology company Lyell Immunopharma, are partnering to develop manufacturing processes designed to create more... Read more
Detects two independent SARS-CoV-2 viral RNA targets from respiratory samples for increased confidence Differentiates SARS-CoV-2 from four other endemic human coronaviruses for specificity Validated with Bruker-Hain GenoXtract® NA and GenoXtract® 96 X3 nucleic acid extraction system and kits Validated with novel Bruker-Hain FluoroCycler® XT real-time PCR thermocycler NEHREN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today... Read more
Company extends program benefits to oncology laboratories and fast-tracks access to comprehensive molecular profiling on the Genexus System CARLSBAD, Calif., July 27, 2020 /PRNewswire/ — Thermo Fisher Scientific today announced the expansion of its GlobalAccess Sequencing Program to include laboratories working in oncology. Originally introduced to accelerate multi-institutional-led studies focused on SARS-CoV-2, the expanded program now... Read more